G Bertoli
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Cancer-related Molecular Pathways 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Co-authors
- Carlo Baroni (6 shared papers)Ν. Fabris (2 shared papers)C Inferrera (1 shared paper)Rosario Alberto Caruso (1 shared paper)Rino Bellocco (1 shared paper)Michele Pagano (1 shared paper)Luciana Rigoli (1 shared paper)P Alquati (7 shared papers)
- Journals
- British Journal of Cancer (3 papers)Cellular and Molecular Life Sciences (2 papers)Modern Pathology (1 paper)Endoscopy (1 paper)Diabetologia (1 paper)
- Partner nations
- ItalyUnited StatesSweden
In The Last Decade
G Bertoli
23 papers receiving 707 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 210
- Oncology 316
- Immunology 169
- Endocrinology, Diabetes and Metabolism 94
- Gastroenterology 28
Countries citing papers authored by G Bertoli
This map shows the geographic impact of G Bertoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bertoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bertoli more than expected).
Fields of papers citing papers by G Bertoli
This network shows the impact of papers produced by G Bertoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bertoli. The network helps show where G Bertoli may publish in the future.
Co-authors
The 25 scholars most cited alongside G Bertoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 150 | |
| 2 | p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. | 2000 | 103 |
| 3 | 1993 | 89 | |
| 4 | Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. | 1969 | 70 |
| 5 | 2001 | 68 | |
| 6 | Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours. | 1996 | 54 |
| 7 | Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. | 2002 | 41 |
| 8 | 1994 | 38 | |
| 9 | 2003 | 35 | |
| 10 | 1967 | 26 | |
| 11 | 1970 | 12 | |
| 12 | 2003 | 12 | |
| 13 | Effects of hormones on development and function of lymphoid tissues. II. Delayed development of immunological capacity in pituitary dwarf mice. | 1971 | 11 |
| 14 | 1968 | 8 | |
| 15 | 1999 | 6 | |
| 16 | Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma. | 1982 | 5 |
| 17 | 1966 | 4 | |
| 18 | Histochemistry of 3 beta-hydroxysteroid dehydrogenase in human testis in normal, dysgenetic and various pathological conditions. | 1969 | 3 |
| 19 | 1998 | 3 | |
| 20 | Histochemistry of 3 beta-hydroxysteroid dehydrogenase in human adrenal cortex in various pathological conditions. | 1969 | 3 |
About G Bertoli
G Bertoli is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 23 papers that have together received 747 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Genetic factors in colorectal cancer (2 papers), HER2/EGFR in Cancer Research (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Cancer-related Molecular Pathways (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Cancer Research (210 citations), Oncology (316 citations), Immunology (169 citations), Endocrinology, Diabetes and Metabolism (94 citations) and Gastroenterology (28 citations). G Bertoli has collaborated with scholars based in Italy, United States and Sweden. Frequent co-authors include Carlo Baroni, Ν. Fabris, C Inferrera, Rosario Alberto Caruso, Rino Bellocco, Michele Pagano, Luciana Rigoli, P Alquati, Alessandra Bersiga and Alberto Bottini. Their work appears in journals such as British Journal of Cancer, Cellular and Molecular Life Sciences, Modern Pathology, Endoscopy and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.